Unibest 优贝德
登录 / 注册
← 返回专利悬崖列表

CAS 53123-88-9

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-[1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2(R)-yl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-3,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-1H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

登记编号:Umirolimus-004

应用背景(按来源药适应症)

冠状动脉再狭窄Umirolimus冠状动脉病变Umirolimus冠状动脉疾病Umirolimus不稳定型心绞痛Umirolimus缺血Umirolimus缺血性心脏病Umirolimus

来源药(使用该中间体的合成路线)

品种梯队到期年
UmirolimusUmirolimusTier C · 观察 / 贸易-

合成路线中的位置(上下游链)

按路线登记顺序排列,左→右为合成方向;高亮为当前 CAS,其余可点击跳转对应档案。

Umirolimus优化路线步数:2总收率:0.498g(Umirolimus (Free))
2-Ethoxyethanol→2,3,4,5,6-Pentafluorobenzenesulfonyl chloride→Pentafluorobenzenesulfonic acid 2-ethoxyethyl ester→(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-[1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2(R)-yl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-3,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-1H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
Umirolimus优化路线步数:2总收率:1.61g(Umirolimus (Free))
2-Ethoxyethanol→2-Ethoxyethyl 4-chlorobenzenesulfonate→2-Ethoxyethyl trifluoromethanesulfonate→(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-3-[1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2(R)-yl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-3,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-1H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

本站可供应的对应中间体

目录暂未收录该靶点的在售中间体 —— 可直接发起询价,需求会进入撮合池。

本页为中间体 CAS 注册档案:同 CAS 的多条路线登记已合并;后续供应商报价与买方需求以该 CAS 为主键撮合。